CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Jun. 30, 2021			1,789,309
Beginning balance at Jun. 30, 2021		$ 17,046	$ 90	$ 26,802	$ 9,543	$ (19,389)
Increase (Decrease) in Stockholders' Equity
Net income (loss)		(85,857)				(85,857)
Foreign currency translation (Note 1)		(547)			(547)
Issuance of common stock, net of offering costs (in shares)			464,781
Issuance of common stock, net of offering costs		37,205	$ 23	37,182
Stock-based compensation		1,285		1,285
Recognition of deferred compensation (Note 11)		459			459
Net restricted stock activity (in shares)			20,939
Net restricted stock activity		(544)	$ 1	(545)
Ending balance (in shares) at Jun. 30, 2022			2,275,029
Ending balance at Jun. 30, 2022		(30,953)	$ 114	64,724	9,455	(105,246)
Increase (Decrease) in Stockholders' Equity
Net income (loss)		(7,385)				(7,385)
Foreign currency translation (Note 1)		(448)			(448)
Stock-based compensation		2,077		2,077
Recognition of deferred compensation (Note 11)		16			16
Net restricted stock activity (in shares)			2,799
Net restricted stock activity		$ (37)		(37)
Ending balance (in shares) at Jun. 30, 2023		2,277,828	2,277,828
Ending balance at Jun. 30, 2023		$ (36,730)	$ 114	66,764	9,023	(112,631)
Increase (Decrease) in Stockholders' Equity
Net income (loss)		91,060				91,060
Foreign currency translation (Note 1)		(321)			(321)
Stock-based compensation		1,622		1,622
Recognition of deferred compensation (Note 11)		(118)			(118)
Net restricted stock activity (in shares)			2,120
Net restricted stock activity		(18)		(18)
Stock warrants issued in connection with debt	[1]	$ 1,292		1,292
Ending balance (in shares) at Jun. 30, 2024		2,279,948	2,279,948
Ending balance at Jun. 30, 2024		$ 56,787	$ 114	$ 69,660	$ 8,584	$ (21,571)

[1] This activity represents the stock warrants issued in connection with the new credit facility agreement signed June 24, 2024. Stock warrant value shown net of allocated financing costs. See Note 8 and Note 14 for additional details.